DETECT IV - A Study in Patients With HER2-negative Metastatic Breast Cancer and Persisting HER2-negative Circulating Tumor Cells (CTCs).
This study is currently recruiting participants.
Verified June 2017 by Prof. W. Janni, University of Ulm
Prof. W. Janni
First Posted: January 14, 2014
Last Update Posted: June 8, 2017
Information provided by (Responsible Party):
Prof. W. Janni, University of Ulm
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Study Completion Date:||No date given|
|Estimated Primary Completion Date:||December 2019 (Final data collection date for primary outcome measure)|